Dompé Farmaceutici
↗Milan, Italy
Dompé is a leading Italian biopharmaceutical company with over 130 years of history, headquartered in Milan. The company is family-owned and has evolved from a traditional primary care pharmacy into a global biotech innovator focused on high-unmet-need areas such as ophthalmology, rare diseases, and pain management. Dompé is notable for being the first company to successfully engineer and commercialize recombinant human nerve growth factor (rhNGF).
The company operates a major R&D and production hub in L'Aquila, Italy, and has a significant presence in the United States and China. Dompé leverages advanced technology platforms, including 'Exscalate,' an AI-driven virtual screening platform, to accelerate drug discovery and development across its diverse pipeline of biologics and small molecules.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Ophthalmology & Rare Disease Biotech
SIZE & FINANCIALS
Employees:501-1000
Revenue:$1B-$5B
Founded:1890
Ownership:private
Status:operating
FUNDING
Stage:Late Stage
Investors:Dompé Holdings
PIPELINE
Stage:Commercial
Lead Drug Stage:Approved (Oxervate)
Modalities:Recombinant proteins, Small molecule, mAb, NGF-based therapies
Active Trials:10
Trial Phases:Phase 1: 2 | Phase 2: 4 | Phase 3: 3 | Phase 4: 1
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Parent Company:Dompé Holdings S.r.l.
Subsidiaries:Dompé U.S. Inc., Movendo Technology
Key Partnerships:Leonardo (Digital health infrastructure), Eni (Health research via Exscalate), Eurofins Discovery (AI-powered drug discovery)
COMPETITION
Position:Leader in neurotrophic keratitis and a major European mid-cap biotech player.
Competitors:Chiesi Farmaceutici, Recordati, AstraZeneca, Novartis
LEADERSHIP
Key Executives:
Sergio Dompé - Executive President
Nathalie Dompé - Co-CEO
Eriona Gjinukaj - Chief Operating Officer
Marcello Allegretti - Chief Scientific Officer
Scientific Founders:Onorato Dompé
Board Members:Sergio Dompé, Nathalie Dompé
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Dompé Farmaceutici. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.